Conn’s Current Therapy 2026

Trusted by clinicians for more than 75 years, Conn’s Current Therapy presents today’s evidence-based information along with the personal experience and discernment of expert physicians. The 2026 edition is a helpful resource for a wide range of healthcare providers, including primary care physicians, subspecialists, and allied health professionals, providing current treatment information in a concise yet in-depth format. Nearly 350 topics have been carefully reviewed and updated to bring you state-of-the-art content in even the most rapidly changing areas of medicine.

• Offers personal approaches from recognized leaders in the field, covering common complaints, acute diseases, and chronic illnesses along with the most current evidence-based clinical management options.
• Follows a consistent, easy-to-use format throughout, with diagnosis, therapy, drug protocols, and treatment pearls presented in quick-reference boxes and tables for point-of-care answers to common clinical questions.
• Contains updated literature and guidelines throughout the text, covering key topics such as chest pain, fatigue, hypertension, GERD, inflammatory bowel disease, diabetic ketoacidosis, thyroid disorders, glaucoma, Alzheimer’s disease, Parkinson disease, traumatic brain injury, sleep disorders, depression and anxiety, cancer, osteoarthritis and osteoporosis, skin disorders, pregnancy and postpartum care, obesity, UTIs, burns, immunization practices, and much more.
• Features thoroughly reviewed information from multiple expert authors and editors, who offer a fresh perspective and their unique personal experience and judgment.
• Provides current drug information thoroughly reviewed by PharmDs.
• Features nearly 300 images, including algorithms, anatomical illustrations, and photographs, that provide useful information for management.
• An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.